{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:55:10Z","timestamp":1790481310963,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.intimp.2024.113608","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T10:40:26Z","timestamp":1731667226000},"page":"113608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"P3","title":["Pyroptosis mediated by Parkin-NLRP3 negative feedback loop contributed to Parkinson\u2019s disease induced by rotenone"],"prefix":"10.1016","volume":"143","author":[{"given":"Dongyan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixi","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duanqin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhefan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlai","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiewen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liya","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10423","key":"10.1016\/j.intimp.2024.113608_b0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson's disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.intimp.2024.113608_b0010","doi-asserted-by":"crossref","first-page":"e464","DOI":"10.1016\/S2666-7568(24)00094-1","article-title":"Temporal trends in the prevalence of Parkinson's disease from 1980 to 2023: a systematic review and meta-analysis","volume":"5","author":"Zhu","year":"2024","journal-title":"Lancet Healthy Longev"},{"issue":"1","key":"10.1016\/j.intimp.2024.113608_b0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41531-023-00568-z","article-title":"Linking environmental risk factors with epigenetic mechanisms in Parkinson's disease","volume":"9","author":"Tsalenchuk","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"issue":"5","key":"10.1016\/j.intimp.2024.113608_b0020","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/ee\/nvac072","article-title":"Efficacy of matrine, rotenone, and pyrethrin against red imported fire ant solenopsis invicta (hymenoptera: formicidae) and their impact on aquatic organisms","volume":"51","author":"Liang","year":"2022","journal-title":"Environ. Entomol."},{"issue":"6","key":"10.1016\/j.intimp.2024.113608_b0025","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1289\/ehp.1002839","article-title":"Rotenone, paraquat, and Parkinson's disease","volume":"119","author":"Tanner","year":"2011","journal-title":"Environ. Health Perspect."},{"issue":"1","key":"10.1016\/j.intimp.2024.113608_b0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/10599240801986215","article-title":"Pesticide\/environmental exposures and Parkinson's disease in East Texas","volume":"13","author":"Dhillon","year":"2008","journal-title":"J. Agromed."},{"key":"10.1016\/j.intimp.2024.113608_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101263","article-title":"Oxidative stress and regulated cell death in Parkinson's disease","volume":"67","author":"Dionisio","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.intimp.2024.113608_b0040","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.freeradbiomed.2023.12.045","article-title":"Clozapine-N-oxide protects dopaminergic neurons against rotenone-induced neurotoxicity by preventing ferritinophagy-mediated ferroptosis","volume":"212","author":"Sun","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2024.113608_b0045","doi-asserted-by":"crossref","first-page":"4477492","DOI":"10.1155\/2023\/4477492","article-title":"MALAT1 mediates alpha-synuclein expression through miR-23b-3p to induce autophagic impairment and the inflammatory response in microglia to promote apoptosis in dopaminergic neuronal cells","volume":"2023","author":"Geng","year":"2023","journal-title":"Mediators Inflamm."},{"issue":"5","key":"10.1016\/j.intimp.2024.113608_b0050","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1021\/acschemneuro.2c00579","article-title":"UBA52 Attunes VDAC1-mediated mitochondrial dysfunction and dopaminergic neuronal death","volume":"14","author":"Tiwari","year":"2023","journal-title":"Acs Chem. Neurosci."},{"key":"10.1016\/j.intimp.2024.113608_b0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbi.2024.03.038","article-title":"Pyroptosis-mediator GSDMD promotes Parkinson's disease pathology via microglial activation and dopaminergic neuronal death","volume":"119","author":"Zhang","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.intimp.2024.113608_b0060","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1007\/s12035-023-03713-0","article-title":"TREM2 deficiency aggravates NLRP3 inflammasome activation and pyroptosis in MPTP-induced Parkinson's disease mice and LPS-induced BV2 cells","volume":"61","author":"Huang","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113608_b0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s13721-024-00445-6","article-title":"MicroRNA-gene regulatory network of TLR signaling in neuroinflammation-induced Parkinson\u2019s disease: a bioinformatics approach","volume":"13","author":"Singh","year":"2024","journal-title":"Network Model. Analy. Health Inform. Bioinform."},{"key":"10.1016\/j.intimp.2024.113608_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101915","article-title":"Understanding the involvement of innate immunity and the Nrf2-NLRP3 axis on mitochondrial health in Parkinson's disease","volume":"87","author":"Rajan","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.intimp.2024.113608_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175300","article-title":"NLRP3 inflammasomes: a potential target to improve mitochondrial biogenesis in Parkinson's disease","volume":"934","author":"Khot","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113608_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112247","article-title":"Oridonin exerts anticonvulsant profile and neuroprotective activity in epileptic mice by inhibiting NLRP3-mediated pyroptosis","volume":"134","author":"Zhao","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2024.113608_b0085","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/cns.13837","article-title":"Fine particulate matter exposure aggravates ischemic injury via NLRP3 inflammasome activation and pyroptosis","volume":"28","author":"Gao","year":"2022","journal-title":"Cns Neurosci. Ther."},{"issue":"46","key":"10.1016\/j.intimp.2024.113608_b0090","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi8716","article-title":"Anionic nanoplastic contaminants promote Parkinson's disease-associated alpha-synuclein aggregation","volume":"9","author":"Liu","year":"2023","journal-title":"Sci. Adv."},{"issue":"8","key":"10.1016\/j.intimp.2024.113608_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087178","article-title":"Defective mitochondrial dynamics and protein degradation pathways underlie cadmium-induced neurotoxicity and cell death in Huntington's disease striatal cells","volume":"24","author":"Kamitsuka","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2024.113608_b0100","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1152\/physrev.00041.2021","article-title":"Mitochondrial quality control in health and in Parkinson's disease","volume":"102","author":"Eldeeb","year":"2022","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.intimp.2024.113608_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101816","article-title":"Proteostasis in Parkinson's disease: recent development and possible implication in diagnosis and therapeutics","volume":"84","author":"Kulkarni","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"46","key":"10.1016\/j.intimp.2024.113608_b0110","doi-asserted-by":"crossref","first-page":"13942","DOI":"10.1021\/acs.jafc.1c04190","article-title":"Rotenone-induced neurodegeneration is enabled by a p38-Parkin-ROS signaling feedback loop","volume":"69","author":"Chen","year":"2021","journal-title":"J. Agric. Food Chem."},{"issue":"2","key":"10.1016\/j.intimp.2024.113608_b0115","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/toxsci\/kfaa066","article-title":"Coordinated action of miR-146a and parkin gene regulate rotenone-induced neurodegeneration","volume":"176","author":"Jauhari","year":"2020","journal-title":"Toxicol. Sci."},{"issue":"15","key":"10.1016\/j.intimp.2024.113608_b0120","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.neuron.2022.05.009","article-title":"Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson's disease","volume":"110","author":"Panicker","year":"2022","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.intimp.2024.113608_b0125","doi-asserted-by":"crossref","first-page":"e13834","DOI":"10.1111\/acel.13834","article-title":"Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's disease","volume":"22","author":"Yan","year":"2023","journal-title":"Aging Cell"},{"key":"10.1016\/j.intimp.2024.113608_b0130","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2147\/JAA.S467774","article-title":"NLRP3 inflammasome deficiency alleviates inflammation and oxidative stress by promoting PINK1\/parkin-mediated mitophagy in allergic rhinitis mice and nasal epithelial cells","volume":"17","author":"Ding","year":"2024","journal-title":"J. Asthma Allergy"},{"key":"10.1016\/j.intimp.2024.113608_b0135","article-title":"NLRP3 deficiency protects against intermittent hypoxia-induced neuroinflammation and mitochondrial ROS by promoting the PINK1-parkin pathway of mitophagy in a murine model of sleep Apnea","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113608_b0140","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12974-021-02349-y","article-title":"p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease","volume":"18","author":"Chen","year":"2021","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.intimp.2024.113608_b0145","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/s41467-020-14931-8","article-title":"Cerebellum-enriched protein INPP5A contributes to selective neuropathology in mouse model of spinocerebellar ataxias type 17","volume":"11","author":"Liu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2024.113608_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.114630","article-title":"PARP1 promotes NLRP3 activation via blocking TFEB-mediated autophagy in rotenone-induced neurodegeneration","volume":"252","author":"Zhang","year":"2023","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.intimp.2024.113608_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176819","article-title":"Experimental models of Parkinson's disease: challenges and opportunities","volume":"980","author":"Lal","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2024.113608_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084148","article-title":"Biomarker of neuroinflammation in Parkinson's disease","volume":"23","author":"Liu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2024.113608_b0165","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3233\/ADR-230128","article-title":"Dimethyl fumarate exerts a neuroprotective effect by enhancing mitophagy via the NRF2\/BNIP3\/PINK1 axis in the MPP(+) iodide-induced Parkinson's disease mice model","volume":"8","author":"Pinjala","year":"2024","journal-title":"J. Alzheimers Dis. Rep."},{"issue":"8","key":"10.1016\/j.intimp.2024.113608_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107543","article-title":"BL-918 activates PINK1\/Parkin signaling pathway to ameliorate the progression of Parkinson's disease","volume":"300","author":"Wang","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"Pt B","key":"10.1016\/j.intimp.2024.113608_b0175","article-title":"Formoterol attenuated mitochondrial dysfunction in rotenone-induced Parkinson's disease in a rat model: role of PINK-1\/PARKIN and PI3K\/Akt\/CREB\/BDNF\/TrKB axis","volume":"125","author":"Khidr","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2024.113608_b0180","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev.Immunol"},{"key":"10.1016\/j.intimp.2024.113608_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110063","article-title":"Inhibition of NLRP3 inflammasome ameliorates LPS-induced neuroinflammatory injury in mice via PINK1\/Parkin pathway","volume":"257","author":"Wang","year":"2024","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.intimp.2024.113608_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054628","article-title":"LPS triggers acute neuroinflammation and parkinsonism involving NLRP3 inflammasome pathway and mitochondrial CI dysfunction in the rat","volume":"24","author":"Valenzuela-Arzeta","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.intimp.2024.113608_b0195","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.neuron.2022.06.015","article-title":"Taking the parkin brakes off of neuronal NLRP3 drives inflammasome activation and neurodegeneration in Parkinson's disease","volume":"110","author":"Zengeler","year":"2022","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.intimp.2024.113608_b0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023660","article-title":"Lipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-kappa B","volume":"6","author":"Tran","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.intimp.2024.113608_b0205","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2024.113608_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.148954","article-title":"Neuroprotective role of Carvacrol via Nrf2\/HO-1\/NLRP3 axis in Rotenone-induced PD mice model","volume":"1836","author":"Shah","year":"2024","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.intimp.2024.113608_b0215","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4103\/NRR.NRR-D-23-00595","article-title":"Additive neurorestorative effects of exercise and docosahexaenoic acid intake in a mouse model of Parkinson's disease","volume":"20","author":"Kerdiles","year":"2025","journal-title":"Neural Regen. Res."},{"issue":"3","key":"10.1016\/j.intimp.2024.113608_b0220","article-title":"Overcoming challenges of clinical cell therapies for Parkinson's disease with photobiomodulation","volume":"2","author":"Chamkouri","year":"2024","journal-title":"Interdisciplinary Med."},{"issue":"5","key":"10.1016\/j.intimp.2024.113608_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e16195","article-title":"Curcumin protects against rotenone-induced Parkinson's disease in mice by inhibiting microglial NLRP3 inflammasome activation and alleviating mitochondrial dysfunction","volume":"9","author":"Xu","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.intimp.2024.113608_b0230","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12974-023-02759-0","article-title":"Inflammasome inhibition protects dopaminergic neurons from alpha-synuclein pathology in a model of progressive Parkinson's disease","volume":"20","author":"Grotemeyer","year":"2023","journal-title":"J. Neuroinflamm."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924021301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924021301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T23:25:30Z","timestamp":1733959530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924021301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":46,"alternative-id":["S1567576924021301"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113608","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyroptosis mediated by Parkin-NLRP3 negative feedback loop contributed to Parkinson\u2019s disease induced by rotenone","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113608","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113608"}}